We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock
CTIC

Delisted

CTIC was delisted on the 23rd of June, 2023.

Back to rankings

2 hedge funds and large institutions have $474K invested in CTI BioPharma Corp. (DE) Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 131 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more call options, than puts

Call options by funds: $9K | Put options by funds: $2K

98% less funds holding

Funds holding: 133 → 2 (-131)

100% less capital invested

Capital invested by funds: $475M → $474K (-$475M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 131

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-131
Holders Change %
-98.5%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
131
Calls
$9K
Puts
$2K
Net Calls
+$7K
Net Calls Change
-$1.45M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$52.2M
2
RCMNY
Rubric Capital Management (New York)
New York
-$37.6M
3
BI
BVF Inc
California
-$37M
4
BlackRock
BlackRock
New York
-$29.8M
5
SCM
Stonepine Capital Management
Oregon
-$27.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
– -$871K -207,270 Closed
KCM
52
Kennedy Capital Management
Missouri
– -$743K -176,809 Closed
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
– -$639K -152,126 Closed
William Blair & Company
54
William Blair & Company
Illinois
– -$556K -132,413 Closed
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
– -$531K -126,408 Closed
AllianceBernstein
56
AllianceBernstein
Tennessee
– -$463K -110,200 Closed
TC
57
Tejara Capital
United Kingdom
– -$462K -110,000 Closed
Squarepoint
58
Squarepoint
New York
– -$450K -107,053 Closed
CM
59
Caption Management
Oklahoma
– -$420K -100,000 Closed
LA
60
Lakeside Advisors
Washington
– -$400K -95,280 Closed
State of Wisconsin Investment Board
61
State of Wisconsin Investment Board
Wisconsin
– -$393K -93,683 Closed
Skandinaviska Enskilda Banken (SEB)
62
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$376K -89,502 Closed
CS
63
Credit Suisse
Switzerland
– -$376K -89,490 Closed
JF
64
Jump Financial
Illinois
– -$365K -86,865 Closed
Nomura Holdings
65
Nomura Holdings
Japan
– -$360K -85,648 Closed
Mirae Asset Global Investments
66
Mirae Asset Global Investments
South Korea
– -$342K -81,452 Closed
DFCM
67
Dark Forest Capital Management
Puerto Rico
– -$327K -77,849 Closed
HighTower Advisors
68
HighTower Advisors
Illinois
– -$302K -71,982 Closed
E
69
Ergoteles
New York
– -$296K -70,371 Closed
EFM
70
E Fund Management
China
– -$271K -64,520 Closed
Deutsche Bank
71
Deutsche Bank
Germany
– -$260K -61,859 Closed
Qube Research & Technologies (QRT)
72
Qube Research & Technologies (QRT)
United Kingdom
– -$254K -60,459 Closed
VEA
73
Virtus ETF Advisers
New York
– -$220K -52,472 Closed
MIM
74
MetLife Investment Management
New Jersey
– -$204K -48,688 Closed
AIG
75
American International Group
New York
– -$203K -48,327 Closed
1 2
3
4 5

CTIC Hedge Fund Activity: Q2 2023 in Review

2 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q2 2023, worth a combined $474K — down 100% from $475M a quarter earlier.

Sellers outnumbered buyers: 131 funds closed out of CTIC and 0 opened new positions — a net loss of 131 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was State Street, exiting entirely with an estimated $52.2M sold.

  • 2 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q2 2023, down from 133 in Q1 2023.
  • Funds reported $474K of CTI BioPharma Corp. (DE) Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q2 2023 and 131 closed out, a net change of -131 holders.
  • The largest CTI BioPharma Corp. (DE) Common Stock seller in Q2 2023 was State Street, an estimated $52.2M sold.

Based on aggregated 13F filings for Q2 2023.